Table 2.

Antibiotic treatment before heart transplant and as surgery prophylaxis.

	mdr/xdr Infections (n = 14)	Non-mdr/xdr Infections (n = 21)	Not Infected (n = 12)	p
Ab therapy previous 7 days; n (%)	4 (28.6)	4 (19)	4 (33.3)	ns
Amoxicillin/Clavulanic acid	1 (7.1)	2 (9.5)	2 (16.7)	0.704
Meropenem	1 (7.1)	1 (4.8)	0	0.999
Linezolid	0	1 (4.8)	1 (8.3)	0.728
Vancomycin	0	1 (4.8)	0	1
Cefepime	0	1 (4.8)	0	1
Piperacillin/tazobactam	0	1 (4.8)	0	1
Levofloxacin	0	1 (4.8)	0	1
Colistin	1 (7.1)	0	0	0.553
Daptomycin	1 (7.1)	0	2 (16.7)	0.093
Minocycline	1 (7.1)	0	0	0.553
Trimethoprim/sulfamethoxazole	1 (7.1)	0	1 (8.3)	0.300
Gentamicin	0	0	1 (8.3)	0.255
Antibiotic prophylaxis;n (%)
Amoxicillin/Clavulanic acid	12 (85.7)	16 (76.2)	11 (91.7)	0.616
Colistin	0	0	1 (8.3)	0.255
Meropenem	1 (7.1)	1 (4.8)	0	0.999
Vancomycin	2 (14.3)	4 (19)	1 (8.3)	0.872
Cefepime	0	1 (4.8)	0	1
Daptomycin	0	1 (4.8)	0	1

Abbreviations: ns, non-significant.